Cadian Capital Management, LP Catalent, Inc. Transaction History

Cadian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $161 Million - $172 Million	-3,009,834 Reduced 93.3%	216,000 $12.1 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $121 Million - $170 Million	-2,838,550 Reduced 46.81%	3,225,834 $182 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $24.4 Million - $35.4 Million	759,600 Added 14.32%	6,064,384 $272 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $112 Million - $127 Million	2,526,750 Added 90.95%	5,304,784 $242 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $88.5 Million - $187 Million	2,778,034 New	2,778,034 $120 Million

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cadian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cadian Capital Management, LP with notifications on news.